Shishir Agarwal, managing director of Terumo India, said, “We are delighted to introduce ReDS™ Pro, which represents the gold standard for monitoring and managing heart failure patients, to Indian healthcare. We look forward to working with Sensible Medical in bringing the ReDS™ Pro device to every hospital in India to support them in managing their patients more effectively.”
Commenting on the development, Amir Ronen, Sensible Medical’s CEO said, “There is a severe need for a reliable tool to assess and monitor pulmonary congestion, which is paramount to guide heart failure treatment. We are excited to work together with Terumo India in this new long-term partnership, to make ReDS™ Pro available in India and improve patient care.”
